Jean-Pierre Loza

Senior Financial Analyst @In Extenso Finance

Paris, FR

Review listed companies financial statements and analyze revenues, R&D costs and expenses, risks; Conduct qualitative analysis of financial data for forecast revenues, identify future trend, assess risk associated with capital expenditures, acquisitions for biotech firms. Create and deliver reports, presentations, providing recommendations for biotechnology companies- Active: IMPLANET, PHERECYDES PHARMA, PREDILIFE, QUANTUM GENOMICS, TME PHARMA.

Harvard Medical School

Postgraduate Degree

Université de Technologie de Compiègne

Doctor of Philosophy - PhD